Allostera Pharma, Inc.
Pharmaceuticals - Montreal, Quebec, Canada
Allostera Pharma, Inc. Employees
Allostera Pharma, Inc. Details
Allostera Pharma Inc. is a biopharmaceutical company headquartered in Montreal that has developed an entirely new class of pre-clinical drugs, called Allosteramers™. Allosteramers™ have three main properties: 1) they are "allosteric", meaning they do not bind to the same site as traditional drugs potentially providing better safety, efficacy and an entirely new set of patentable intellectual properties, 2) they can have predictable and consistent drug properties, and 3) they are designed to be orally available. Allostera's technology to develop Allosteramers™, called Module X, allows target to lead generation of Allosteramers™ within months. Using its this platform, Allostera has developed several novel Allosteramers™ against different targets primarily focused on inflammation and autoimmunity including APG2305, an oral drug inhibiting a very important target, IL23R.
Allostera Pharma, Inc. Technologies
Ad Servers
DoubleClick
Hosting
Amazon AWS
Other
Mobile Friendly
Analytics and Tracking
Hotjar